| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.3 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.03 | 0.3 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.047 | 0.3 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |